• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解人类肠道微生物组在超重和肥胖中的作用。

Understanding the role of the human gut microbiome in overweight and obesity.

机构信息

Department of Human Health & Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada.

Division of Biochemical and Molecular Biology, Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts, USA.

出版信息

Ann N Y Acad Sci. 2024 Oct;1540(1):61-88. doi: 10.1111/nyas.15215. Epub 2024 Sep 16.

DOI:10.1111/nyas.15215
PMID:39283061
Abstract

The gut microbiome may be related to the prevalence of overweight and obesity, but high interindividual variability of the human microbiome complicates our understanding. Obesity often occurs concomitantly with micronutrient deficiencies that impair energy metabolism. Microbiota composition is affected by diet. Host-microbiota interactions are bidirectional. We propose three pathways whereby these interactions may modulate the gut microbiome and obesity: (1) ingested compounds or derivatives affecting small intestinal transit, endogenous secretions, digestion, absorption, microbiome balance, and gut barrier function directly affect host metabolism; (2) substrate availability affecting colonic microbial composition and contact with the gut barrier; and (3) microbial end products affecting host metabolism. The quantity/concentration, duration, and/or frequency (circadian rhythm) of changes in these pathways can alter the gut microbiome, disrupt the gut barrier, alter host immunity, and increase the risk of and progression to overweight and obesity. Host-specific characteristics (e.g., genetic variations) may further affect individual sensitivity and/or resilience to diet- and microbiome-associated perturbations in the colonic environment. In this narrative review, the effects of selected interventions, including fecal microbiota transplantation, dietary calorie restriction, dietary fibers and prebiotics, probiotics and synbiotics, vitamins, minerals, and fatty acids, on the gut microbiome, body weight, and/or adiposity are summarized to help identify mechanisms of action and research opportunities.

摘要

肠道微生物组可能与超重和肥胖的流行有关,但人体微生物组的个体间高度可变性使我们对其的理解变得复杂。肥胖通常伴随着影响能量代谢的微量营养素缺乏。微生物组的组成受饮食影响。宿主-微生物组的相互作用是双向的。我们提出了三种可能调节肠道微生物组和肥胖的相互作用途径:(1)摄入的化合物或衍生物直接影响小肠转运、内源性分泌、消化、吸收、微生物组平衡和肠道屏障功能,从而影响宿主代谢;(2)底物可用性影响结肠微生物组成和与肠道屏障的接触;(3)微生物终产物影响宿主代谢。这些途径中的变化的数量/浓度、持续时间和/或频率(昼夜节律)可以改变肠道微生物组,破坏肠道屏障,改变宿主免疫,并增加超重和肥胖的风险和进展。宿主特异性特征(例如遗传变异)可能进一步影响个体对饮食和微生物组相关的结肠环境扰动的敏感性和/或弹性。在这篇叙述性综述中,总结了包括粪便微生物群移植、饮食热量限制、膳食纤维和益生元、益生菌和合生菌、维生素、矿物质和脂肪酸在内的一些干预措施对肠道微生物组、体重和/或肥胖的影响,以帮助确定作用机制和研究机会。

相似文献

1
Understanding the role of the human gut microbiome in overweight and obesity.了解人类肠道微生物组在超重和肥胖中的作用。
Ann N Y Acad Sci. 2024 Oct;1540(1):61-88. doi: 10.1111/nyas.15215. Epub 2024 Sep 16.
2
The Gut Microbiota: The Gateway to Improved Metabolism.肠道微生物群:改善新陈代谢的关键
Gastroenterol Clin North Am. 2016 Dec;45(4):601-614. doi: 10.1016/j.gtc.2016.07.001.
3
Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.饮食、肠道微生物群与肥胖:与宿主遗传学和表观遗传学的关联及其潜在应用。
Adv Nutr. 2019 Jan 1;10(suppl_1):S17-S30. doi: 10.1093/advances/nmy078.
4
The role of the microbiome for human health: from basic science to clinical applications.微生物组对人类健康的作用:从基础科学到临床应用。
Eur J Nutr. 2018 May;57(Suppl 1):1-14. doi: 10.1007/s00394-018-1703-4.
5
Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.肠道微生物组及其对肥胖和肥胖相关疾病的影响。
Curr Gastroenterol Rep. 2023 Feb;25(2):31-44. doi: 10.1007/s11894-022-00859-0. Epub 2022 Dec 5.
6
Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.微生物失调诱导的肥胖:肠道微生物群在能量代谢稳态中的作用。
Br J Nutr. 2020 May 28;123(10):1127-1137. doi: 10.1017/S0007114520000380. Epub 2020 Feb 3.
7
Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).肠道微生物群与肥胖:通过粪便微生物群移植(FMT)改变肥胖的机会。
Diabetes Obes Metab. 2019 Mar;21(3):479-490. doi: 10.1111/dom.13561. Epub 2018 Nov 20.
8
Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.针对肠道微生物群治疗多种疾病的不同策略:一种可持续的方法。
Infect Disord Drug Targets. 2024;24(5):e160124225675. doi: 10.2174/0118715265267536231121095634.
9
Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.结直肠癌治疗中肠道微生物组修饰的治疗方法 - 粪便微生物移植、益生元、益生菌和合生菌。
Gut Microbes. 2020 Nov 1;11(6):1518-1530. doi: 10.1080/19490976.2020.1764309. Epub 2020 May 26.
10
GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.肠道微生物群、益生元、益生菌和合生菌在肥胖和糖尿病管理中的应用:随机对照试验综述。
Endocr Pract. 2016 Oct;22(10):1224-1234. doi: 10.4158/EP151157.RA. Epub 2016 Jul 13.

引用本文的文献

1
Differential effects of switching to integrase strand transfer inhibitors on the gut microbiota and markers of HIV disease progression.转换为整合酶链转移抑制剂对肠道微生物群及HIV疾病进展标志物的不同影响。
BMC Microbiol. 2025 Sep 1;25(1):569. doi: 10.1186/s12866-025-04313-9.